Genomic Prediction, Inc.

Medical device company · North Brunswick, New Jersey, United States

Genomic Prediction, Inc. is a medical device company headquartered in North Brunswick, New Jersey, United States. Its earliest recorded incorporation is in 2017. It has reported private securities offerings to the US SEC, most recently $12 million sold in a notice filed in 2021.

Profile compiled from public records. Is this your company? Request a correction or update

Genomic Prediction at a glance

Typemedical device company
HeadquartersNorth Brunswick, New Jersey, United States
Earliest incorporation on record2017
SEC CIK1897345

What does Genomic Prediction do?

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $12 million sold (2021).

Frequently asked questions about Genomic Prediction

Where is Genomic Prediction headquartered?

Genomic Prediction, Inc. is headquartered in North Brunswick, New Jersey, United States.

What does Genomic Prediction do?

Genomic Prediction, Inc. is a medical device company.

When was Genomic Prediction founded?

The earliest incorporation on record for Genomic Prediction, Inc. is in 2017, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences